The Procter & Gamble Company (NYSE:PG) Shares Purchased by Whelan Financial

Whelan Financial lifted its position in The Procter & Gamble Company (NYSE:PGFree Report) by 20.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,453 shares of the company’s stock after acquiring an additional 419 shares during the period. Whelan Financial’s holdings in Procter & Gamble were worth $398,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in PG. Wellington Management Group LLP boosted its stake in Procter & Gamble by 9.4% during the third quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock worth $5,193,916,000 after buying an additional 3,047,557 shares during the last quarter. Norges Bank acquired a new position in shares of Procter & Gamble in the 4th quarter valued at $3,956,117,000. Charles Schwab Investment Management Inc. lifted its stake in shares of Procter & Gamble by 1.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 16,209,425 shares of the company’s stock valued at $2,336,552,000 after purchasing an additional 206,165 shares during the last quarter. Fisher Asset Management LLC lifted its stake in shares of Procter & Gamble by 5.6% in the 4th quarter. Fisher Asset Management LLC now owns 10,556,988 shares of the company’s stock valued at $1,547,021,000 after purchasing an additional 559,358 shares during the last quarter. Finally, Franklin Resources Inc. lifted its stake in shares of Procter & Gamble by 2.6% in the 4th quarter. Franklin Resources Inc. now owns 9,571,693 shares of the company’s stock valued at $1,402,636,000 after purchasing an additional 246,323 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Procter & Gamble

In related news, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total value of $4,581,309.81. Following the completion of the sale, the insider now directly owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, CEO Gary A. Coombe sold 21,388 shares of the company’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $164.98, for a total value of $3,528,592.24. Following the completion of the sale, the chief executive officer now directly owns 36,854 shares of the company’s stock, valued at approximately $6,080,172.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total value of $4,581,309.81. Following the completion of the sale, the insider now directly owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The disclosure for this sale can be found here. In the last ninety days, insiders sold 154,544 shares of company stock valued at $25,413,051. 0.17% of the stock is currently owned by corporate insiders.

Procter & Gamble Price Performance

Shares of NYSE PG opened at $163.83 on Friday. The stock’s 50-day moving average is $165.74 and its two-hundred day moving average is $159.22. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $169.41. The company has a market cap of $386.66 billion, a price-to-earnings ratio of 26.77, a price-to-earnings-growth ratio of 3.13 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.10. The business had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The business’s quarterly revenue was up .6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.37 EPS. Analysts forecast that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were given a dividend of $1.0065 per share. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a dividend yield of 2.46%. The ex-dividend date was Thursday, April 18th. Procter & Gamble’s dividend payout ratio is currently 65.85%.

Analyst Ratings Changes

Several brokerages have recently commented on PG. Deutsche Bank Aktiengesellschaft decreased their price target on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. Barclays upped their price target on Procter & Gamble from $168.00 to $170.00 and gave the company an “overweight” rating in a research note on Tuesday, April 23rd. Argus boosted their price objective on Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a report on Thursday, April 25th. StockNews.com upgraded Procter & Gamble from a “hold” rating to a “buy” rating in a report on Tuesday, June 25th. Finally, BNP Paribas initiated coverage on Procter & Gamble in a report on Monday, June 24th. They issued an “outperform” rating and a $187.00 price objective on the stock. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $170.72.

View Our Latest Analysis on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.